ANN ARBOR, Mich., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, announced today that Future Materials Magazine is featuring the Company in an article titled “Strong as Silk”, as well as on the magazine’s cover.
The feature may be accessed at the following link:
The article “Strong as Silk” begins on page 17.
"The technical textile markets are enormous in size and scope. Though we believe we have identified several key users for our products, this type of exposure is vital to expanding our audience. It’s a great honor to be featured in this edition of Future Materials Magazine. The magazine’s geographic and industry footprint provides us a combination of additional publicity and potential product development opportunities,” said Kraig COO, Jon Rice.
“We are thrilled to receive coverage in this edition of Future Materials Magazine, which reaches many of our relevant audiences around the world," said Kraig CEO and founder, Kim K. Thompson. “Our genetically engineered spider silk is an amazing material and it is rewarding to see it recognized in Future Materials Magazine.”
Future Materials is published by the World Textile Information Network (WTiN). Established more than 100 years ago, WTiN is a world leading textile news and information provider. WTiN's magazines & Online Products (WTiN Intelligence, Textile Cost Manager, Textile Database) - have long been recognized for their authority and market-leading coverage.
For more information regarding WTiN go to: www.WTiN.com
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc